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Abstract
Background: Household water treatment can improve the microbiological quality of drinking water and may prevent
diarrheal diseases. However, current methods of treating water at home have certain shortcomings, and there is evidence of
bias in the reported health impact of the intervention in open trial designs.
Methods and Findings: We undertook a randomised, double-blinded, placebo-controlled trial among 240 households (1,144
persons) in rural Democratic Republic of Congo to assess the field performance, use and effectiveness of a novel filtration
device in preventing diarrhea. Households were followed up monthly for 12 months. Filters and placebos were monitored for
longevity and for microbiological performance by comparing thermotolerant coliform (TTC) levels in influent and effluent
water samples. Mean longitudinal prevalence of diarrhea was estimated among participants of all ages. Compliance was
assessedthroughself-reporteduseandpresenceofwaterinthe topvesselofthedeviceatthetimeofvisit.Overthe12-month
follow-up period, data were collected for 11,236 person-weeks of observation (81.8% total possible). After adjusting for
clustering within the household, the longitudinal prevalence ratio of diarrhoea was 0.85 (95% confidence interval: 0.61–1.20).
The filters achieved a 2.98 log reduction in TTC levels while, for reasons that are unclear, the placebos achieved a 1.05 log
reduction (p,0.0001). After 8 months, 68% of intervention households met the study’s definition of current users, though
most (73% of adults and 95% of children) also reported drinking untreated water the previous day. The filter maintained a
constant flow rate over time, though 12.4% of filters were damaged during the course of the study.
Conclusions: While the filter was effective in improving water quality, our results provide little evidence that it was
protective against diarrhea. The moderate reduction observed nevertheless supports the need for larger studies that
measure impact against a neutral placebo.
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Introduction
Diarrhoea is responsible for 1.8 million deaths annually, mostly
among children under five in developing countries[1]. Much of
this disease burden is attributable to unsafe water, poor hygiene
and sanitation[2]. An estimated 884 million people worldwide lack
access to improved water sources[3]; hundreds of millions more
rely on improved sources that are not consistently safe for
drinking. Even water that is safe at the point of distribution often
becomes contaminated during collection, transport and storage
within the home due to poor hygiene conditions and practices[4].
While safe, reliable, piped-in water is an essential goal, treating
water at the household or other point of consumption provides a
means by which vulnerable populations can improve the quality of
their own drinking water[5]. The practice is widespread, with
hundreds of millions reporting that they usually treat their water at
home before drinking it [6].
There is also evidence that household water treatment is
protective against diarrhoea [7,8,9] though research suggests that
placebo effect and reporting bias play a role in the estimate of
effect reported in open trials[10,11,12,13]. Placebo-controlled
trials of chlorine-based interventions have been conducted [14,15],
but apart from a recent study in Ghana[16], none have assessed
the neutrality of the placebo or the effectiveness of the blinding,
and other issues have been raised about their methodological
quality. Filters are more difficult to blind among populations
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contains no filter medium is readily identified by comparing its
effluent with the effective filter. However, a placebo that removes
turbidity to ensure blinding will probably also remove pathogens
that tend to adhere to the suspended solids; it may also create
adsorption sites or promote biofilm adhesion that will also render
the ‘‘placebo’’ at least somewhat effective in removing pathogens.
To date, the only placebo-controlled trials of household-based
filters have been conducted in the United States with municipally
treated water that is low in turbidity but also met WHO water
quality standards[16,17,18,19]. Thus, these results cannot be
generalised to settings with turbid and contaminated water.
Several water treatment methods have been promoted in low-
income settings, including disinfection, disinfection/flocculation,
ceramic filtration, solar disinfection and boiling[5].Each has
limitations in terms of microbiological effectiveness, cost, accept-
ability, environmental impact, and sustainability among target
populations[20]. Moreover, except for boiling, none of these
interventions have achieved scale except in limited settings [6].
This has led to calls for alternative technologies that are effective
against the full array of microbial pathogens, that can be deployed
and used at a large scale with minimum programmatic support,
and that will be embraced by the target population[21].
The Lifestraw FamilyH is a newly developed household-based
gravity filter that employs hollow-fibre membranes to remove
waterborne pathogens by ultrafiltration. Independent laboratory
testing has shown the device to meet the US Environmental
Protection Agency (USEPA) standards for bacteria, viruses and
protozoan cysts[22]. The device is designed to treat a minimum of
18,000 L of water and assumed to last for about three years. The
manufacturer, Vestergaard-Frandsen SA of Lausanne, Switzer-
land, plans to sell the filter in large volumes for about US$20.
Methods
Study design; sample size calculation
The study was designed as a randomised, double-blinded,
placebo-controlled trial. Our primary outcome was longitudinal
prevalence of diarrhea defined as the number of weeks with
diarrhea divided by the total number of weeks under observation.
The study was powered to detect a 30% reduction in the mean
longitudinal diarrhoea between the two groups. This was a
conservative estimate in comparison with the pooled risk reduction
of 63% calculated from six previous studies of household filters[8].
The calculation assumed 80% power, a=0.05, a baseline
longitudinal prevalence of diarrhoea of 5%, and a coefficient of
variation of 2. In order to account for potential lost to follow-up
(10%) as well as clustering of diarrhoea within household and
intermittent surveillance (7-day period prevalence measured
repeatedly once a month over the 12-month follow-up period)
(10%), we estimated that we needed at least 600 individuals in
each arm. Assuming a mean of 5 persons per household, the
number of households to be recruited was approximately 120 per
arm, or 240 households in total. The protocol for this trial
(Protocol S1) and CONSORT checklist (Checklist S1) are
available as supporting information.
Setting and participant eligibility
The study was conducted from April 2008 to July 2009 in the
rural health zone of Bibanga, 80 km from the city of Mbuji-Mayi
in the eastern province of Kasai, the Democratic Republic of
Congo (DRC). Despite abundant water resources, more than three
quarters of the population in rural areas in the DRC rely on
unimproved water sources for drinking, mainly surface water and
unprotected springs[23]. With the assistance of the Presbyterian
Church of Kinshasa, which has been supporting community
health programmes in this area for many years, and staff at the
health zone level, we identified possible study sites. Selected
communities relied on unimproved water sources that tested over
1000 thermotolerant coliforms (TTC)/100 ml, reported low use of
household water treatment, were easily accessible all year round
from the reference hospital of Bibanga where the field team was
established, and were motivated to take part in the project. In
order to meet the sample size requirements, the study was
conducted in two neighbouring villages.
Intervention
Each intervention household received a Lifestraw Family filter
and each control household received a placebo. The Lifestraw
Family is a gravity-fed microbiological water purifier. Water is
poured into a 2.5 L plastic vessel, passes through a 27-mm pre-
filter, and flows down a 1 m long plastic pipe before passing
through the filtration cartridge comprised of hollow-fibres with a
20-nm pore size. The top vessel contains a slow eluding chlorine
tablet designed to prevent biofilm formation and increase the life
of the cartridge. Treated water is accessed from the side of the
cartridge via a tap. The device is cleaned daily by rinsing the pre-
filter and backwashing the cartridge using a squeeze-pump and
outlet valve mounted on the bottom of the cartridge. The device is
designed to treat at least 18,000 L of water with a flow rate of
approximately 150 ml per minute or 9 L per hour. In the
laboratory, the filter was found to meet the USEPA standards for
microbiological water purifiers by reducing bacteria by 6.9 logs,
viruses by 4.7 logs and protozoan cysts by 3.6 logs [22].
Placebo
The placebo had the same configuration, appearance and
external components as the Lifestraw Family except that (i) the
chlorine tablet was removed from the upper vessel to prevent
possible microbicidal action, (ii) the filtration membranes were
replaced by some extra piping to imitate the weight and effluent
flow rate of the real cartridge, and (iii) the 27-mm screen on the
pre-filter was removed to minimise retention of microbes adhering
to suspended solids. Three weeks of testing in the laboratory
confirmed that the placebo removed no bacteria, viruses and
protozoan cysts from test water. Despite the challenge in blinding
household filters, we determined after piloting that blinding the
intervention would be feasible in our study area because the water
had low turbidity, ranging from ,5 nephelometric turbidity units
(NTU) for most of the year to 10 NTU during heavy rains.
Enrolment, baseline survey, randomization and filter
deployment
After discussing the proposed study with community leaders and
obtaining consent from the heads of households, a baseline survey
was undertaken in April 2008 to collect information on
demographics, socio-economic characteristics, and water, hygiene
and sanitation practices. Data collection tools were translated in
Tshiluba, the local language, and piloted before use. Following the
baseline survey, households were randomly assigned to one of the
two groups using a random number generator. Randomisation
was stratified by village and was conducted by the trial manager
who played no part in the collection of the data. Both the
intervention and the placebo were distributed door-to-door by five
trained field workers who were unaware of whether the device was
an active filter or a placebo. Householders were trained on use and
maintenance of the device according to the manufacturer’s
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from the tap and not to store filtered water in order to prevent
recontamination. The start of follow-up period was delayed by two
months due to initial technical problems with the filters.
Blinding
The allocation sequence was concealed from both field
investigators and the study population. In order to blind the
intervention among assessors, field workers were divided into two
teams. The team responsible for assessing health outcomes was
neither involved in the distribution of the filters at the
commencement of the trial nor in the assessment of the filter
performance and use during follow-up. Any questions from the
householders that were related to the filter were referred to and
dealt with by the filter assessment team.
Outcome Assessment
Diarrhoea. Investigators interviewed the female head of
household or primary care giver of young children once each
month over a 12-month period. They recorded any diarrhoea
cases in the preceding seven days. Diarrhoea was defined as three
or more loose stools passed within a 24-hour period. In an effort to
further obscure the outcome of interest from the target population,
field assessors also inquired about and recorded presence of fever
and cough within the past seven days. Children with diarrhoea
were given oral rehydration sachets and instructions on how to use
them. When necessary, they were referred to the closest
community health post to receive medical care free of charge.
Fever and cough were also treated among young children.
Filter monitoring. Each month, a random sample of 30
filters and 30 placebos (25% of the total number distributed) was
monitored. At each household visit, field workers noted the
location and condition of the filter and recorded if the respondent
was able to use and clean the filter correctly. Filter components
found to be damaged were replaced. Flow rate was monitored by
filling the top container with 2.5 L of water, opening the tap and
measuring the time necessary to fill a 125 ml container with water.
The flow rate was expressed in ml per minute.
Water quality. Influent and effluent paired water samples
were collected for each of the selected devices. If the respondent
mentioned storing the water once filtered, a third sample was
collected from the container designated as the treated water
storage vessel. All samples were collected in sterile 125 ml Nalgene
sampling bottles and assessed for thermotolerant coliforms (TTC)
within 4 h after collection. Microbiological assessment was
performed using the membrane filtration technique (APHA
Standard Methods) on membrane lauryl sulphate medium (Oxoid
Limited, Basingstoke, Hampshire, UK) using a DelAgua field
incubator (Robens Institute, University of Surrey, Guilford,
Surrey, UK). Microbiological performance of the filters was
expressed in terms of log reduction value (LRV) calculated as the
log of the influent concentration divided by the effluent
concentration (log10 influent/effluent).
Compliance. Cross-sectional surveys were conducted among
each household eight and fourteen months after distribution.
Participants were classified as current users if they reported using
the filter ‘today or yesterday’ and if the field investigator found the
filter hung for use with water in the top vessel of the device.
Consistency of use was estimated by asking the respondent if he/
she had drunk unfiltered water within the previous day. The
survey covered further aspects on use and acceptability.
Blinding assessment. Immediately following the conclusion
of the follow-up period, we assessed the effectiveness of blinding
among participants. Blinding indices were calculated using
methods developed by James and colleagues [24]and Bang and
colleagues[25] Female heads of household or primary care giver
were asked to identify which device they had received. Surveys
were targeted at the respondents to the health surveys because
they would be most likely to be influenced by their belief in
treatment assignment.
Data analysis
The analysis of the primary outcome was on an intention-to-
treat basis. We used Poisson regression with robust standard errors
to estimate the effect of the intervention on the longitudinal
prevalence of diarrhea and other health outcomes[26]. We used
generalized estimating equations (GEE) to account for clustering at
the household level. Categorical data were compared using a Chi
square or a Fisher’s exact test where appropriate. Continuous
variables were compared with a Student t test. Statistical analyses
of microbiological data were conducted after log10 transformation
of TTC counts to normalize the distribution. Data analysis was
conducted in Stata (Stata Corporation, College Station, Texas,
US).
Ethics
The study was reviewed and approved by the ethics committee
at the London School of Hygiene and Tropical Medicine and the
ethics committee at the School of Public Health in Kinshasa.
Written consent to participate in the research was obtained from
community leaders and the head of each participating household.
Investigators explained that half of the study population would be
receiving effective microbiological purifiers while the others would
receive placebos and that householders should continue their
existing water management practices since their device may not be
protective against microbial contamination. At the conclusion of
the follow-up period, all placebo filters were replaced by effective
filters. Following the completion of the study, the results were
communicated to all study participants.
Results
Participant flow
259 households initially volunteered to participate in the study.
Nineteen households were excluded because they did not reside in
the selected villages; they relied primarily on spring water for
drinking, or subsequently elected not to participate. A total of 240
households were enrolled; 120 were assigned to receive the
Lifestraw Family filter and 120 the placebo. Over the 12-month
follow-up period, data were collected for 11,236 (81.8%) possible
person-weeks of observation. Data were missing for 2492 weeks
(18.2%) due primarily to participants leaving the study area or
being absent at the time of visit (Figure 1). Over the study period,
twenty participants died, six of them were children under the age
of five. The number of deaths was 12 in the intervention group
and 8 in the control group (p=0.27).
Baseline surveys
Intervention and control groups were similar in terms of
demographic and socio-economic characteristics and hygiene and
sanitation practices (Table 1). Almost all households primarily used
river water for drinking. However, intervention households were
more likely to store their water in clay pots and access it by dipping
a cup into the container compared with control households who
often used jerrycans. Only four households reported treating their
water sometimes or rarely by boiling or adding bleach. Only 37%
of households had a latrine and 51% had soap present in the house
at the time of visit (Table 1).
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At baseline, the prevalence of diarrhoea was similar in both
groups (12.6% versus 10.6% for control and intervention groups,
respectively). Over the 12-month follow-up period, participants of
all ages who received the active filter experienced 15% fewer
weeks with diarrhoea compared to those who received a placebo
(mean, 2.66 versus 3.15, respectively). However, the confidence
interval of the longitudinal prevalence ratio (LPR) adjusted for
clustering within the household (LPR 0.85, 95% CI 0.61; 1.20) was
wide and included 1. The longitudinal prevalence ratio among
children under five was 0.85 (95%CI 0.56; 1.28). Figure 2 shows
the prevalence of diarrhoea between intervention and control over
time. We observed no difference in the mean longitudinal
prevalence of fever (LPR 0.99; 95% CI 0.80; 1.22) or cough
(LPR 0.99; 95% CI 0.81; 1.22) between the two groups. Health
outcome data are presented in Table 2.
Water quality
Each device was tested on average 3 times during follow-up. 580
(81%) of the total possible paired water samples were collected.
Missing samples are due to householders being absent or not being
in possession of their filter at the time of visit. Source drinking
water was highly contaminated, with 75% of household samples
showing contamination levels above 1000 TTC/100 ml (Figure 3).
The active filter achieved a LRV of 2.98 (95% CI 2.88, 3.08),
removing about 99.8% of the indicator bacteria. Overall, 64% of
Figure 1. CONSORT diagram showing the flow of participants through the trial.
doi:10.1371/journal.pone.0012613.g001
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TTC levels between 1–10 TTC/100 ml. None of the filters
produced water with .100 TTC/100 ml consistently over the
three visits. Samples from placebos were also contaminated, with
73% of the water samples containing between 100–1000 TTC/
100 ml. However, unlike the results from laboratory testing that
Table 1. Baseline characteristics of participating households.
Control Intervention Total
N% N% N %
Demographic and socio-economic
Number of households 120 (50) 120 (50) 240 (100)
Number of persons 598 (52.3) 546 (47.7) 1144 (100)
Number of households with children ,5 66 (55) 57 (47.5) 123 (51.2)
Number of children ,5 105 (17.6) 85 (15.8) 190 (16.6)
Mean number of persons per household 5.0 4.5 4.8
Mean number of rooms in the house 2.2 2.3 2.3
Respondent is female 76 (63.3) 76 (63.3) 152 (63.3)
Mean age of respondent 37.5 40.8 39.1
Level of education
No formal education 47 (39.2) 38 (31.7) 85 (35.4)
Primary 44 (60.3) 45 (54.9) 89 (57.4)
Secondary 29 (39.7) 36 (43.9) 65 (41.9)
Higher 0 (0) 1 (1.2) 1 (0.6)
Owns
House 113 (94.2) 116 (96.7) 229 (95.4)
Land 115 (95.8) 117 (97.5) 232 (96.7)
Livestock 59 (49.2) 64 (53.8) 123 (51.5)
Radio 27 (22.7) 34 (28.3) 61 (25.5)
Phone 10 (8.3) 16 (13.3) 26 (10.8)
Bicycle 18 (15) 16 (13.3) 34 (14.2)
Hygiene and sanitation
Use soap to wash hands 54 (45) 54 (45) 108 (45)
Presence of soap at the time of visit 65 (54.2) 59 (49.2) 124 (51.7)
Received hygiene advice in past 6 months 4 (3.4) 10 (8.4) 14 (5.9)
Presence of latrine 47 (39.2) 41 (34.2) 88 (36.7)
Water handling practices
Primary source of drinking water
River 120 (100) 117 (97.5) 237 (98.7)
Rainwater 44 (36.7) 46 (38.3) 90 (37.5)
Spring 15 (12.5) 19 (15.8) 34 (14.2)
Type of drinking water container
Clay pot 68 (56.7) 83 (69.2) 151 (62.9)
Jerry can 50 (41.7) 30 (25) 80 (33.3)
Other 2 (1.7) 7 (5.8) 9 (3.7)
Vessel opening
Wide mouth 71 (59.2) 92 (76.7) 163 (67.9)
Narrow mouth 49 (40.8) 28 (23.3) 77 (32.1)
Storage vessels covered 111 (93.3) 113 (95.0) 224 (94.1)
Means of obtaining water
Pour 48 (41.0) 27 (23.3) 75 (32.2)
Dip 69 (59.0) 89 (76.7) 158 (67.8)
Treat water* 3 (2.5) 1 (0.8) 4 (1.7)
*Treat water sometimes (n=1) or rarely (n=3). Treatment methods boil (n=2), bleach (n=1), water settle (n=1).
doi:10.1371/journal.pone.0012613.t001
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the field showed that the placebo actually removed more than
90% of the TTC from source water (LRV 1.05, 95% CI: 0.93,
1.16).
Flow rate
The mean flow rate of the filters over the study period was
202 ml/min (95% CI 198, 206) or 12 L/hour. It declined slightly
over time (21.5 ml/min per month, p,0.002).
Figure 2. Prevalence of diarrhoea over the course of the study among participants of all ages.
doi:10.1371/journal.pone.0012613.g002
Table 2. Longitudinal prevalence of diarrhoea and other health conditions by age and treatment group.
Mean longitudinal prevalence LPR (95% CI) LPR* (95%CI)
Control Intervention
Weeks of
illness
Person-weeks
of observation % Weeks ill
Weeks
of illness
Person-weeks
of observation % Weeks ill
Diarrhoea
,5 96 1072 8.96 60 801 7.49 0.84 (0.61; 1.14) 0.85 (0.56; 1.28)
5–15 31 1880 1.65 29 1765 1.64 1.00 (0.60; 1.65) 0.91 (0.49; 1.67)
.15 59 2945 2.00 52 2752 1.89 0.94 (0.65; 1.36) 0.95 (0.61; 1.57)
All ages** 186 5907 3.15 142 5329 2.66 0.85 (0.68; 1.05) 0.85 (0.61; 1.20)
Fever
,5 249 1072 23.23 187 801 23.35 1.00 (0.85; 1.19) 1.02 (0.79; 1.30)
5–15 99 1880 5.27 123 1765 6.97 1.32 (1.02; 1.71) 1.28 (0.89; 1.85)
.15 226 2945 7.67 188 2752 6.83 0.89 (0.74; 1.07) 0.91 (0.68; 1.22)
All ages** 576 5907 9.75 500 5329 9.38 0.96 (0.86; 1.08) 0.99 (0.80; 1.22)
Cough
,5 196 1072 18.28 162 801 20.22 1.11 (0.92; 1.33) 1.11 (0.85; 1.43)
5–15 163 1880 8.67 142 1765 8.05 0.93 (0.75; 1.50) 0.89 (0.63; 1.27)
.15 192 2945 6.52 201 2752 7.30 1.12 (0.93; 1.35) 1.07 (0.82; 1.39)
All ages** 551 5907 9.33 505 5329 9.48 1.01 (0.90; 1.14) 0.99 (0.81; 1.22)
*Adjusted for clustering within household.
**Age missing for 3 participants.
doi:10.1371/journal.pone.0012613.t002
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Over half of the respondents (56%) correctly demonstrated how
to clean the filters. The pre-filter was cleaned at each use (40%) or
once a day (41%), wheareas the cartrige was generally backwashed
once a day (67%). Overall, 36 (12.4%) of the 290 active filters
tested were found damaged during visits, mainly due to rodents
chewing on the soft hoses (n=35). Intervention households
reported liking the filter due to improved aesthetics (88%), taste
(92%), odour (56%) and health (35%). Reasons for dissatisfaction
were slow flow rate (87%), small size of the top container (85%)
and problems with rats (44%).
Compliance
Eight months after distribution, 183 (76%) of the households
were present at the time of visit and were still in possession of their
filter. 68% of respondents in the intervention group could be
defined as current users against 48% in the placebo group
(p,0.001). However, nearly all adults (83%) and young children
(95%) also reported drinking untreated water in the previous day.
Fourteen months after distribution, the proportion of current users
was slightly higher in both groups (76% versus 69% among
intervention and control groups, respectively). Additional details
about use are included in Table 3. Subgroup analysis showed no
evidence of an association between use and diarrhoea morbidity
(Table 4).
Blinding status
Table 5 shows respondent guesses for each treatment assign-
ment groups. James’ method, similar to the kappa statistics,
produced a blinding index (BI) score of 0.42 (95%CI 0.38; 0.46). A
score of 0 means that all respondents guessed correctly, 1 indicates
that all respondents guessed incorrectly and 0.5 indicates random
guessing. Bang’s method calculates the proportion of correct
guesses beyond chance in each treatment group. Bang’s BI was
0.96 (95%CI 0.90; 0.99) for the intervention group and 20.63
(95%CI 20.73; 20.53) for the placebo-controlled group. Bang’s
blinding index varies from 21 to 1. 1 indicates complete lack of
blinding, 21 opposite guess about treatment assignment and 0
random guessing. Subgroup analysis showed no evidence of an
association between diarrhoea and respondents’ guesses.
Discussion
We undertook the first double-blinded, placebo-controlled trial
of household-based water filters in a low-income setting with water
known to be contaminated with faecal pathogens. This design
sought to assess the impact of the intervention in the absence of
respondents’ bias that is common in open trials. Due to challenges
of developing a placebo in such settings and to successfully
blinding the intervention, we monitored placebo performance and
conducted a post-intervention assessment of blinding among study
participants. Filter performance and health impact were moni-
tored for a full year to account for seasonal variations and
minimise the potential for exaggerated health impact often
associated with shorter-term trials [9].
After adjusting for clustering, members of intervention house-
holds had 15% fewer weeks of diarrhoea than those of control
households, but the confidence intervals indicated little statistical
support (longitudinal prevalence ratio 0.85, 95%CI: 0.61 to 1.20).
With the exception of a recent study in the United States among
an elderly population
17, this finding is consistent with other
placebo-controlled trials of household water treatment interven-
tions [14,15,16] which found no protective effect against
diarrhoea. However, as we have observed elsewhere, those studies
may have had insufficient power to identify a statistically
significant impact on diarrhoea[27]. Our sample size also was
not sufficiently large to detect a statistically significant difference in
diarrhoea of 15%. Moreover, the baseline prevalence of diarrhoea
was lower than anticipated and the clustering effect due to
repeated measurement and household randomisation was higher.
Pos-hoc sample size calculations indicated that we would have
Figure 3. Percentage of water samples by level of contamination (TTC/100 ml).
doi:10.1371/journal.pone.0012613.g003
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Control Intervention Total
n% n% n %
MONTH 8
Last use (n=183)*
Previous day 44 (48.3) 63 (68.5) 107 (58.5)
Previous week 30 (33.0) 14 (15.2) 44 (24.0)
.1 week ago 17 (18.7) 15 (16.3) 32 (17.5)
Consistency of use on previous day (n=107)
Respondent drank unfiltered water 43 (97.7) 46 (73.0) 89 (83.2)
Children (,5) drank unfiltered water 31 (93.9) 39 (95.1) 70 (94.6)
Filter accessible to young children 1 (2.3) 6 (9.5) 7 (6.5)
Store filtered water for young children 4 (12.9) 8 (19.5) 12 (16.7)
Additional details on use in previous day (n=107)
Respondent drank unfiltered water when
In the field 33 (76.7) 39 (78.3) 72 (77.9)
In a hurry to drink 30 (69.8) 33 (71.7) 63 (70.8)
Away from village 16 (37.2) 15 (32.6) 31 (34.8)
Other 3 (7.0) 12 (26) 15 (16.8)
Children drank unfiltered water when
Person operating the filter not present 21 (67.7) 31 (79.5) 52 (74.3)
In a hurry to drink 11 (35.5) 23 (59.0) 34 (48.6)
Away from home 10 (32.3) 13 (33.3) 23 (32.9)
Other 5 (16.1) 7 (17.9) 12 (17.1)
Did not store filtered water for children:
No container 17 (68) 28 (87.1) 45 (78.9)
Lock the door 6 (24) 3 (9.3) 9 (15.8)
Don’t want to always filter, too slow 2 (8) 0 (0) 2 (3.5)
Told not to store water 0 (0) 1 (3.1) 1 (1.7)
MONTH 14
Last use (n=190)**
Previous day 63 (69.2) 75 (75.8) 138 (72.6)
Previous week 14 (15.4) 11 (11.1) 25 (13.2)
.1 week ago 14 (15.4) 13 (13.3) 27 (14.2)
*197 (82%) households present at the time of visit; 183 (93%) of them were still in possession of the filter and ever used it.
**203 (85%) households present at the time of visit; 192 (94%) of them were still in possession of the filter and ever used it + answer missing for 2 households.
doi:10.1371/journal.pone.0012613.t003
Table 4. Longitudinal prevalence of diarrhoea stratified by reported last time of use.
Mean longitudinal prevalence of diarrhoea LPR (95% CI)
Control Intervention
Weeks of
illness
Person-weeks of
observation % weeks ill
Weeks of
illness
person-weeks of
observation % weeks ill
8 months
User 71 2475 2.87 74 3155 2.35 0.82 (0.59; 1.13)
Non-user 68 2420 2.81 41 1319 3.11 1.11 (0.75; 1.62)
14 months
User 102 3463 2.95 99 3894 2.54 0.86 (0.66; 1.10)
Non-user 49 1642 2.98 27 1025 2.63 0.88 (0.55; 1.40)
doi:10.1371/journal.pone.0012613.t004
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Moreover, the placebo was not microbiologically neutral, as it
removed about 90% of faecal bacteria from the source water used
by control households. The reasons for this apparent effectiveness
are not clear. Field staff responsible for water quality testing were
extensively trained and supervised throughout the study, thereby
minimizing the risk of measurement errors. One of the most
plausible explanations is the formation of a biofilm resulting from
adhesion of suspended solid particles and bacteria on the inner
surface of the plastic pipe forming the placebo cartridge. The
effectiveness of the placebo rendered our trial a comparison
between a 1-log filter and a 3-log filter. Studies have reported an
association between 1 log removal of faecal bacteria from drinking
water and a reduction in diarrhoeal disease [28,29]. Our results
may therefore understate the effectiveness of the active filter if it
were compared to a true placebo. These results suggest that in this
setting with relatively high levels of microbial contamination in
source water, a filter of superior microbiological performance may
be more effective at preventing diarrhoea than one that removes
only 90% of waterborne pathogens. This finding, if validated in
future studies, would support the need for high performance
standards in water treatment devices in order to optimize health
benefits.
The blinding of the intervention was not successful. In both
treatment groups, the vast majority of survey respondents believed
that they had received the active filter, although this proportion
was significantly lower in the placebo group. Unsuccessful blinding
means that we cannot rule out the possibility that the observed
effect on diarrhoea is unbiased. However, the interpretation of
blinding indices is not always clear[30]. The fact that a large
proportion of control households remained blinded throughout the
trial suggests that respondents’ bias may have at least been partly
reduced. The smaller effect size we observed here may be
indicative of a less biased estimate compared with open trials. Our
estimate is similar to the pooled estimate of effect of open trials of
ceramic filters after adjustment for lack of blinding[13]. The fact
that ‘control’ health conditions (fever and cough) remained
unchanged by the intervention also suggests that blinding may
have been effective, although the usefulness of this approach to
detect the presence of respondents’ bias has not been validated.
Including a third arm with no intervention would have provided a
better understanding of the role of bias in this study.
Under field conditions, the Lifestraw Family filters were
effective in removing faecal bacteria from source water. Two-
thirds of filtered water samples were free of faecal coliforms while
most of the remaining samples had low levels of contamination.
The fact that specific filters did not consistently produce
contaminated water suggests that contamination may have
occurred during collection of the sample, perhaps from the tap.
The flow rate was higher than that observed in laboratory
conditions, possibly due to lower water turbidity at the study site
(compared to lab testing at 15 NTU) or inconsistent use by
householders. The damage rate was high although the most
common problems were due to rats eating the soft plastic
components.
Eight monthsafterdistribution,two-thirds oftherespondentsmet
the study’s definition of current users, although almost none of them
drank filtered water exclusively. This pattern of use was seen among
both adults and children under five. Participants drank unfiltered
water when spending time outside their home, but also when they
felt eager to drink and did not want to wait for filtration. Young
children did not have access to the filter when their parents were
away from home. In accordance with the manufacturer’s
instructions, householders were advised to use water directly from
the filter and not to store treated water due to the risk of
recontamination. Consistent with these instructions, almost none of
the households stored filtered water for their children, though many
lacked a storage container even if they had chosen to do so. The
manufacturer has advised that in future deployment of the filters, it
will consider changes in instructions to encourage safe storage of
treatedwaterorprovidea storagevesselforthefiltered watertohelp
increase exclusive consumption of treated water, especially by this
vulnerable group of young children. However, there is also evidence
that even occasional consumption of untreated water may eliminate
the protective effect of water treatment[31] and changes to the
configuration of the filter may not be sufficient to increase exclusive
use unless accompanied by fundamental changes in behaviour to
increase compliance.
Our study had certain additional limitations. The study sites
were not randomly selected, but were chosen based on eligibility
criteria that included high levels of faecal contamination in source
water and high prevalence of diarrhoea at baseline. Accordingly,
these results are not necessarily generalizable to other populations
in the Congo or beyond. Second, the use of a seven-day recall
period is known to produce less precise estimates compared with a
48-hour recall period[32].
Our study provides little evidence of a protective effect of the
filter against diarrhoea. Nevertheless, an effect of 15%, which we
observed but could not confirm here, would represent a substantial
impact on diarrhoea, a major killer of young children. Future
studies with sufficient power to detect this effect size will be
necessary to determine the magnitude of any effect against a
neutral placebo and to confirm that the effect is not attributable to
chance. Our study also demonstrates the need to monitor placebo
performance and the challenge of blinding household-based water
treatment interventions under adverse conditions.
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